AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25745751 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (Cb2) 0.5 mg oral per day for 8 consecutive days starting on the day of hCG administration
Number of subjects: 40
Study 25745751 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 40
Study 25745751 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (Cb2)
Number of subjects: 40
Study 23290081 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrasentan (10 mg)
Number of subjects: 35
Study 23290081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 21592347 — intervention group
Group type: EXPERIMENTAL
Intervention: All Nations Breath of Life (ANBL) program
Number of subjects: 448
Study 21592347 — intervention group
Group type: COMPARATOR
Intervention: Current Best Practices smoking cessation program
Number of subjects: 448
Study 19448514 — intervention group
Group type: EXPERIMENTAL
Intervention: Latex-free leg bag with soft elastic straps and cloth backing
Number of subjects: 43
Study 19448514 — intervention group
Group type: COMPARATOR
Intervention: Latex leg bag with latex straps and noncoated backing
Number of subjects: 43
Study 17031013 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg of vitamin D3 daily
Number of subjects: 49
Study 17031013 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg of vitamin D3 daily
Number of subjects: 49
Study 17031013 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg of vitamin D3 daily
Number of subjects: 49
Study 17031013 — intervention group
Group type: COMPARATOR
Intervention: 0 microg of vitamin D3 daily (placebo)
Number of subjects: 49
Study 12474195 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy weight control intervention
Number of subjects: 148
Study 12474195 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based intervention
Number of subjects: 148
Study 12474195 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 148
Study 11281090 — intervention group
Group type: EXPERIMENTAL
Intervention: FERN Dissemination (FERN-D) program with e-mail discussions
Number of subjects: 34
Study 11281090 — intervention group
Group type: COMPARATOR
Intervention: Preintervention and postintervention surveys
Number of subjects: 34
Study 9314645 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractioned heparin
Number of subjects: 35
Study 9314645 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 35
Study 9314645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 8338443 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyester filters (Optima, Sepacell R500, and Pall RC100)
Number of subjects: 20
Study 8338443 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose acetate filter (Cellselect)
Number of subjects: 20
Study 8338443 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyester filters
Number of subjects: 20
Study 3327683 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (0.075 mg/kg)
Number of subjects: 25
Study 3327683 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine added to beta-blockade
Number of subjects: 25
Study 3327683 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 25
Study 29895045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (34 children) participated in two gaming sessions (1.5 hours each) and an oral presentation about smoking and alcohol risks.
Number of subjects: 67
Study 29895045 — intervention group
Group type: COMPARATOR
Intervention: Control group (33 children) participated in an oral presentation about smoking and alcohol risks.
Number of subjects: 67
Study 27075030 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg of intracuff alkalinized lidocaine
Number of subjects: 80
Study 27075030 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 80
Study 24955797 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg/day cephalexin syrup, administered in four doses for 10 days
Number of subjects: 40
Study 24955797 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study 22156952 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) assisting patients with diabetes in self-management
Number of subjects: 0
Study 22156952 — intervention group
Group type: COMPARATOR
Intervention: Control health centers (without CHWs)
Number of subjects: 0
Study 19966314 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions for procedural pain management
Number of subjects: 28
Study 18798236 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Navigation System (MNS)
Number of subjects: 111
Study 18798236 — intervention group
Group type: COMPARATOR
Intervention: Conventional guidewire techniques
Number of subjects: 111
Study 16397157 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention programs designed based on formative research methods including telephone interviews, surveys, checklists, semistructured interviews, and focus group discussions.
Number of subjects: 0
Study 15259838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 63
Study 15259838 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Expressive Group Psychotherapy (SEGP)
Number of subjects: 63
Study 15259838 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 63
Study 15259838 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 63
Study 11134123 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral DHEA daily for 12 weeks
Number of subjects: 39
Study 11134123 — intervention group
Group type: COMPARATOR
Intervention: Placebo after DHEA treatment
Number of subjects: 39
Study 9072856 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglyconate sutures
Number of subjects: 204
Study 9072856 — intervention group
Group type: COMPARATOR
Intervention: Polyglycolic acid sutures
Number of subjects: 204
Study 8441490 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic energy (Diapulse)
Number of subjects: 50
Study 3023457 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical alpha interferon gel (10^5 U) with nonoxynol 9 applied three times daily for 5 days
Number of subjects: 128
Study 3023457 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical alpha interferon gel (10^7 U) with nonoxynol 9 applied three times daily for 5 days
Number of subjects: 128
Study 3023457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 31206501 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative plasma neutrophil gelatinase‐associated lipocalin levels
Number of subjects: 0
Study 31206501 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour postoperative plasma neutrophil gelatinase‐associated lipocalin levels
Number of subjects: 0
Study 29457585 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Disability Epilepsy Specialist Nurse Competency Framework
Number of subjects: 312
Study 29457585 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 312
Study 27881888 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 24
Study 27881888 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Telmisartan and Ramipril
Number of subjects: 24
Study 27881888 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 24
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-023 75 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-023 150 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-023 300 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: KM-023 600 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of KM-023 75 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of KM-023 600 mg
Number of subjects: 80
Study 25302016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 23176532 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 130
Study 23176532 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 20213036 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling
Number of subjects: 12
Study 20213036 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 12
Study 17631698 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-CAP (sustained-release pellet formulation of diclofenac, 100 mg, once daily)
Number of subjects: 210
Study 17631698 — intervention group
Group type: COMPARATOR
Intervention: SR-TAB (standard reference formulation of diclofenac, 100 mg, once daily)
Number of subjects: 210
Study 17631698 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-CAP
Number of subjects: 210
Study 17631698 — intervention group
Group type: COMPARATOR
Intervention: SR-TAB
Number of subjects: 210
Study 14966017 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal ventilation waveform (OVW) approach with six frequencies from 0.156 to 4.6 Hz
Number of subjects: 6
Study 14966017 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoconstriction (methacholine challenge)
Number of subjects: 6
Study 14966017 — intervention group
Group type: COMPARATOR
Intervention: Seated position
Number of subjects: 6
Study 14966017 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 6
Study 11391056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tridimensional personality questionnaire
Number of subjects: 0
Study 11391056 — intervention group
Group type: EXPERIMENTAL
Intervention: Novelty seeking
Number of subjects: 0
Study 11391056 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality and alcohol/substance use disorder
Number of subjects: 0
Study 11391056 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-pathway psychobiological model
Number of subjects: 0
Study 9839583 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocele group (29 men)
Number of subjects: 57
Study 9839583 — intervention group
Group type: COMPARATOR
Intervention: Control group (28 men)
Number of subjects: 57
Study 9839583 — intervention group
Group type: COMPARATOR
Intervention: Control group (38 men)
Number of subjects: 57
Study 9839583 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocele group (24 men)
Number of subjects: 57
Study 9839583 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study 7859964 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous cefotaxime
Number of subjects: 31
Study 7859964 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic (control)
Number of subjects: 31
Study 2911170 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone acetate 4 mg every six hours for six doses starting at exposure (2700 m)
Number of subjects: 73
Study 2911170 — intervention group
Group type: COMPARATOR
Intervention: Placebo every six hours for six doses starting at exposure (2700 m)
Number of subjects: 73
Study 2911170 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone acetate 4 mg every six hours for six doses starting at exposure (2050 m)
Number of subjects: 73
Study 2911170 — intervention group
Group type: COMPARATOR
Intervention: Placebo every six hours for six doses starting at exposure (2050 m)
Number of subjects: 73
Study 4584707 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mug of Sch 1000
Number of subjects: 20
Study 4584707 — intervention group
Group type: COMPARATOR
Intervention: 200 mug of salbutamol
Number of subjects: 20
Study 30571292 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous walking after breakfast (WALK)
Number of subjects: 30
Study 30571292 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaks from sitting after each meal (BR)
Number of subjects: 30
Study 30571292 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 28473871 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge insoles with custom arch support
Number of subjects: 26
Study 28473871 — intervention group
Group type: COMPARATOR
Intervention: Lateral wedge insoles alone
Number of subjects: 26
Study 26262568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cable Pin System (CPS)
Number of subjects: 73
Study 26262568 — intervention group
Group type: COMPARATOR
Intervention: Tension-Band Wiring (TBW)
Number of subjects: 73
Study 23453439 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 2314
Study 23453439 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 2314
Study 21287560 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (2 × 50 mg/d)
Number of subjects: 55
Study 21287560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 19938199 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal small‐caliber EGD
Number of subjects: 270
Study 19938199 — intervention group
Group type: COMPARATOR
Intervention: Transoral conventional EGD
Number of subjects: 270
Study 16814009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) treatment
Number of subjects: 1873
Study 16814009 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-step treatment
Number of subjects: 1873
Study 15035271 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose mannitol treatment (approximately 1.4 g/kg)
Number of subjects: 44
Study 15035271 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose mannitol treatment (approximately 0.7 g/kg)
Number of subjects: 44
Study 11318075 — intervention group
Group type: EXPERIMENTAL
Intervention: 85% NPH insulin and 15% regular human insulin (85/15)
Number of subjects: 36
Study 11318075 — intervention group
Group type: COMPARATOR
Intervention: 70% NPH/30% regular human insulin (70/30)
Number of subjects: 36
Study 11318075 — intervention group
Group type: COMPARATOR
Intervention: 100% NPH insulin
Number of subjects: 36
Study 9390580 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 58
Study 9390580 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 58
Study 7965607 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who received education about consensus bias and feedback about actual consensus
Number of subjects: 0
Study 7965607 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants attributing bias to another person
Number of subjects: 0
Study 7965607 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants exposed to unanimous information from 20 randomly chosen others
Number of subjects: 0
Study 3580233 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus cisapride 10 mg
Number of subjects: 40
Study 3580233 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus cisapride 4 mg
Number of subjects: 40
Study 3580233 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 10 mg plus placebo
Number of subjects: 40
Study 3580233 — intervention group
Group type: COMPARATOR
Intervention: placebo only
Number of subjects: 40
Study 31351965 — intervention group
Group type: EXPERIMENTAL
Intervention: GZ389988A (tropomyosin receptor kinase A inhibitor)
Number of subjects: 104
Study 31351965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 27900763 — intervention group
Group type: COMPARATOR
Intervention: parecoxib+propacetamol
Number of subjects: 253
Study 27900763 — intervention group
Group type: COMPARATOR
Intervention: parecoxib
Number of subjects: 253
Study 27900763 — intervention group
Group type: COMPARATOR
Intervention: propacetamol
Number of subjects: 253
Study 26520225 — intervention group
Group type: EXPERIMENTAL
Intervention: Singleton detection training
Number of subjects: 0
Study 26520225 — intervention group
Group type: COMPARATOR
Intervention: Feature search training
Number of subjects: 0
Study 21807366 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and implementation modules provided to facility staff
Number of subjects: 45
Study 21807366 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training and implementation modules augmented by surveyor training
Number of subjects: 45
Study 21807366 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 45
Study 21807366 — intervention group
Group type: EXPERIMENTAL
Intervention: Training staff and surveyors
Number of subjects: 45
Study 21035132 — intervention group
Group type: EXPERIMENTAL
Intervention: levobupivacaine (150 mg) + lidocaine (200 mg) + tramadol (100 mg) (Group T)
Number of subjects: 40
Study 21035132 — intervention group
Group type: COMPARATOR
Intervention: levobupivacaine (150 mg) + lidocaine (200 mg) (Group C)
Number of subjects: 40
Study 19536421 — intervention group
Group type: EXPERIMENTAL
Intervention: NutriAlz intervention program
Number of subjects: 946
Study 19536421 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 946
Study 16934043 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 114
Study 16934043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 12628875 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate for 6 weeks followed by nasal saline solution irrigation for 6 weeks
Number of subjects: 61
Study 12628875 — intervention group
Group type: COMPARATOR
Intervention: Nasal saline solution irrigation for 12 weeks (for children without chronic sinusitis)
Number of subjects: 61
Study 12628875 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment for sinusitis
Number of subjects: 61
Study 10671845 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered lidocaine 1%
Number of subjects: 122
Study 10671845 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-irritation technique
Number of subjects: 122
Study 10671845 — intervention group
Group type: COMPARATOR
Intervention: Warmed lidocaine 1%
Number of subjects: 122
Study 9354220 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline instillation (1 mL/kg; maximum 10 mL) before catheter removal
Number of subjects: 404
Study 9354220 — intervention group
Group type: COMPARATOR
Intervention: Control group (no saline instillation)
Number of subjects: 404
Study 8518976 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (100 mg each evening)
Number of subjects: 1
Study 8518976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 2439825 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (4 X 40 mg/day)
Number of subjects: 4
Study 2439825 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol (4 X 100 mg/day)
Number of subjects: 4
Study 2439825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (2 X 5 mg/day)
Number of subjects: 4
Study 2439825 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol (2 mg/day)
Number of subjects: 4
Study 29433687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ze 185
Number of subjects: 72
Study 29433687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 29433687 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 72
Study 30427135 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal equivalent (DE) applied on trophic ulcers in addition to standard treatment
Number of subjects: 60
Study 30427135 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 60
Study 25518175 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based, patient-specific cutting blocks
Number of subjects: 80
Study 25518175 — intervention group
Group type: COMPARATOR
Intervention: Contemporary instrumentation with alignment at 3 degrees external rotation from posterior condylar line
Number of subjects: 80
Study 21982583 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 56
Study 21982583 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 56
Study 20222036 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome-based education on rational prescribing
Number of subjects: 112
Study 20222036 — intervention group
Group type: COMPARATOR
Intervention: Traditional CME program on rational prescribing
Number of subjects: 112
Study 18662287 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine 200 mg b.d.
Number of subjects: 76
Study 18662287 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 76
Study 18662287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 15807806 — intervention group
Group type: EXPERIMENTAL
Intervention: 96-well microplate-based colorimetric method for SC quantification
Number of subjects: 0
Study 15807806 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Squame tape disks
Number of subjects: 0
Study 12408206 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based tailored print material intervention
Number of subjects: 0
Study 12408206 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary telecounseling intervention
Number of subjects: 0
Study 12408206 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (computer-based tailored print material + telecounseling)
Number of subjects: 0
Study 12408206 — intervention group
Group type: COMPARATOR
Intervention: Generic print materials (control group)
Number of subjects: 0
Study 12109042 — intervention group
Group type: COMPARATOR
Intervention: Reference product (3 x 40 mg tablets)
Number of subjects: 24
Study 12109042 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product A (3 x 40 mg tablets)
Number of subjects: 24
Study 12109042 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product B (1 x 120 mg tablet)
Number of subjects: 24
Study 9613910 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20-40 mg daily)
Number of subjects: 6605
Study 7710536 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid
Number of subjects: 52
Study 7710536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 2711525 — intervention group
Group type: EXPERIMENTAL
Intervention: Redon high-vacuum drainage system
Number of subjects: 0